Your browser doesn't support javascript.
loading
Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.
Kok, Chung H; Yeung, David T; Lu, Liu; Watkins, Dale B; Leclercq, Tamara M; Dang, Phuong; Saunders, Verity A; Reynolds, John; White, Deborah L; Hughes, Timothy P.
Afiliação
  • Kok CH; Precision Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA, Australia.
  • Yeung DT; Discipline of Medicine, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
  • Lu L; Precision Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA, Australia.
  • Watkins DB; Discipline of Medicine, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
  • Leclercq TM; Department of Haematology, SA Pathology, Adelaide, SA, Australia.
  • Dang P; Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia; and.
  • Saunders VA; Precision Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA, Australia.
  • Reynolds J; Discipline of Medicine, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
  • White DL; Precision Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA, Australia.
  • Hughes TP; Discipline of Medicine, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
Blood Adv ; 3(10): 1610-1621, 2019 05 28.
Article em En | MEDLINE | ID: mdl-31126916
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Transcriptoma / Mesilato de Imatinib Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Transcriptoma / Mesilato de Imatinib Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article